The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC): Primary analysis of the single arm phase II trial SAKK 06/17.
 
Richard Cathomas
Honoraria - Astellas Pharma; Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology; Pfizer; Roche (Inst); Sanofi (Inst)
 
Sacha Rothschild
Honoraria - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche Pharma AG (Inst); Takeda (Inst)
Other Relationship - Federal Drug Commission of the Swiss Federal Office of Public Health
 
Stefanie Hayoz
No Relationships to Disclose
 
Martin Spahn
No Relationships to Disclose
 
Berna Özdemir
Consulting or Advisory Role - BMS Brazil (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Roche (Inst)
Speakers' Bureau - MSD (Inst); Novartis (Inst)
 
Bernhard Kiss
Stock and Other Ownership Interests - 2Seventy Bio; Allogene Therapeutics; Atreca; Bluebird Bio; Gilead Sciences; Gritstone Bio; Medtronic; Novartis; Siemens Healthcare Diagnostics
Consulting or Advisory Role - Bristol-Myers Squibb; Ferring
 
Andreas Erdmann
No Relationships to Disclose
 
Stefanie Aeppli
Consulting or Advisory Role - Genzyme (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Kantonsspital St. Gallen (Inst)
Travel, Accommodations, Expenses - Janssen
 
Nicolas Mach
Stock and Other Ownership Interests - MaxiVax
Research Funding - MaxiVax
Patents, Royalties, Other Intellectual Property - I am inventor on patent owned by MaxiVAX SA and on patent co-owned by Geneva University Hospital and MaxiVAX SA
(OPTIONAL) Uncompensated Relationships - MaxiVax
 
Raeto Strebel
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Amgen; Astellas Pharma; Bayer; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; BMS; Janssen
 
Dominik R. Berthold
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst)
 
Miklos Pless
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers-Squibb; Eisai Europe; Merck Serono; MSD Oncology; Novartis; Pfizer/EMD Serono; Roche; Takeda
Expert Testimony - Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers-Squibb; Vifor Pharma
 
Deborah Zihler
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck; Pierre Fabre; Sanofi
Travel, Accommodations, Expenses - Janssen
 
Mathias Schmid
No Relationships to Disclose
 
Martina Schneider
No Relationships to Disclose
 
Jana Musilova
No Relationships to Disclose
 
Ulf Petrausch
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); MSD (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); bms (Inst); MSD (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen